citalopram has been researched along with clomipramine in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (17.43) | 18.7374 |
1990's | 31 (28.44) | 18.2507 |
2000's | 31 (28.44) | 29.6817 |
2010's | 26 (23.85) | 24.3611 |
2020's | 2 (1.83) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Eid, NM; George, RF; Hanna, MM; Safwat, HM | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kato, H; Kogure, K; Nakata, N | 1 |
Blier, P; de Montigny, C | 1 |
Chilco, PJ; Donnan, GA; Kaczmarczyk, SJ; Kalnins, RM; Mendelsohn, FA; Paxinos, G; Woodhouse, DG | 1 |
Insel, TR; Winslow, JT | 1 |
Gibb, JW; Hanson, GR; Ritter, JK; Schmidt, CJ | 1 |
Lovenberg, W; Schmidt, CJ | 1 |
Fasmer, OB; Hole, K; Hunskaar, S | 1 |
Andersson, A; Bäckström, I; Marcusson, JO | 1 |
Fuller, RW | 1 |
Briley, M; Moret, C | 1 |
Graham, D; Langer, SZ; Tahraoui, L | 1 |
Eriksson, K; Marcusson, J | 1 |
Collard, KJ; Evans, SM | 1 |
Christensen, P | 1 |
Bech, P; Haaber, A; Joyce, CR | 1 |
Gibb, JW; Schmidt, CJ | 1 |
Conquy, T; Durand, A; Rop, PP; Viala, A | 1 |
Lingjaerde, O | 1 |
Christensen, P; Gram, LF; Kragh-Sørensen, P; Pedersen, OL; Thomsen, HY | 1 |
Pawłowski, L | 1 |
Buckholtz, NS; Sparks, DL | 1 |
Constantinidis, J; Dick, P; Tissot, R | 1 |
Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
Adrien, J; Hamon, M; Maudhuit, C | 2 |
Neuvonen, PJ; Pohjola-Sintonen, S; Tacke, U; Vuori, E | 1 |
Hayakawa, H; Kawai, K; Kikumoto, O; Motohashi, N; Nishida, A; Okamoto, Y; Tanra, AJ; Yamawaki, S | 1 |
Buchholtz-Hansen, PE; Kragh-Sørensen, P; Wang, AG | 1 |
Depierre, JW; Nässberger, L; Xia, Z | 2 |
Bech, P; Damsbo, N; Fuglum, E; Lauritzen, L; Rosenberg, C; Stage, K | 1 |
Berk, M; Koopowitz, LF; Szabo, CP | 1 |
Harnett-Sheehan, K; Sheehan, DV | 1 |
Kagaya, A; Uchitomi, Y; Yamaji, T; Yamawaki, S; Yokota, N | 1 |
Bouwer, C; Stein, DJ; van Heerden, B | 1 |
Appelkvist, EL; DePierre, JW; Nässberger, L; Xia, Z | 1 |
Balant, L; Busquets, X; Escribá, PV; García-Sevilla, JA; Guimón, J; Walzer, C | 1 |
Koponen, HJ; Lepola, U; Pedersen, T; Pedersen, V; Wade, AG | 1 |
Pidrman, V; Tůma, I | 1 |
Betz, H; Schloss, P; Sur, C | 1 |
Stein, MB | 1 |
Bejerot, S; Bodlund, O | 1 |
Meyers, BS | 1 |
Baumann, P; Bryois, C; Buclin, T; Kosel, M; Rubin, C; Voirol, P | 1 |
Bergstrand, A; DePierre, JW; Nässberger, L; Xia, Z | 1 |
Koran, LM; Paiva, RS; Pallanti, S; Quercioli, L | 1 |
Bechtel, PR; Bizouard, P; Broly, F; Haffen, E; Sechter, D; Vandel, P; Vandel, S | 1 |
Koponen, H; Lehto, H; Leinonen, E; Lepola, U; Turtonen, J; Wade, A | 1 |
Ali, Z; Brady, JP | 1 |
Bagi, Z; Kecskeméti, V; Lakó-Futó, Z; Nánási, PP; Pacher, P; Ungvári, Z | 1 |
Bergstrand, A; DePierre, JW; Lundgren, B; Nässberger, L; Xia, Z | 1 |
Auclair, A; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Rivet, JM | 1 |
Brocco, M; Dekeyne, A; La Rochelle, CD; MacSweeny, C; Millan, MJ; Papp, M; Peglion, JL | 1 |
Bellodi, L; Cavallini, MC; Cavedini, P; Diaferia, G; Erzegovesi, S; Locatelli, M | 1 |
Albert, U; Bergesio, C; Bogetto, F; Maina, G; Pessina, E | 1 |
DePierre, JW; Karlsson, H; Nässberger, L; Ying, G | 1 |
Corda, MG; Driscoll, P; Giorgi, O; Hansson, S; Lecca, D; Piras, G | 1 |
Broocks, A; Hohagen, F; Kordon, A | 1 |
Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
Goodman, WK; Hollander, E; Pallanti, S | 1 |
Geday, J; Hermansen, F; Rosenberg, R; Smith, DF | 1 |
Chen, JY; Chen, YA; Tao, PL; Wu, CC; Yeh, GC | 1 |
Coppinger, D; Lin, RC; Lu, Y; Maciag, D; Paul, IA; Simpson, KL; Wang, Y | 1 |
Adkins, EM; Blakely, RD; Field, JR; Henry, LK; Newman, AH; Parnas, ML; Vaughan, RA; Zou, MF | 1 |
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
Drago, F; Leggio, GM; Micale, V | 1 |
Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
Lombion, S; Millot, JL; Morand-Villeneuve, N | 1 |
Aigner, M; Gutierrez-Lobos, K; Hornik, K; Pirker, W; Stompe, T; Thau, K; Wenzel, T; Zettinig, G; Zitterl, W; Zitterl-Eglseer, K | 1 |
Bun'kova, KM | 1 |
Altamura, AC; Buoli, M; Dell'Osso, B; Mundo, E; Zanoni, S | 1 |
Jung, SM; Ravindran, AV; Ravindran, LN | 1 |
Carlini, M; Catena Dell'osso, M; Consoli, G; Golia, F; Marazziti, D; Mungai, F; Pfanner, C; Presta, S | 1 |
Norante, FA; Taft, AS; Yoshino, TP | 1 |
de Vos, A; Loovers, HM; van der Weide, J | 1 |
Drago, F; Leggio, GM; Micale, V; Tamburella, A | 1 |
Avesani, M; Bortolomasi, M; Manganotti, P; Minelli, A; Salvoro, B; Scassellati, C | 1 |
Bhagya, V; Raju, TR; Rao, BS; Srikumar, BN | 1 |
Huston, JP; Klingenhegel, I; Komorowski, M; Paulat, J; Sackers, J; Topic, B | 1 |
Licht, RW | 1 |
Barak, Y; Baratz-Goldstein, R; Hostovsky, A; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I | 1 |
Lubszky, S; Reinhart, WH; Schulzki, T; Thöny, S | 1 |
Andersen, SE; Gislasson, G; Hansen, AH; Holm, EA; Leth-Møller, KB; Torp-Pedersen, C; Torstensson, M; Ødum, L | 1 |
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
Bhave, S; Faye, A; Gawande, S; Kirpekar, V; Tadke, R | 1 |
Cuypers, E; Somers, T; Vandenbosch, M | 1 |
Aydogdu, O; Dankis, M; Tobin, G; Winder, M | 1 |
Asadi-Pooya, AA; Firouzabadi, N; Kashkooli, M; Malekpour, M; Zamiri, B | 1 |
11 review(s) available for citalopram and clomipramine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
From clomipramine to mianserin: therapeutic relevance of interactions with serotonin uptake and storage, as studied in the blood platelet model.
Topics: Antidepressive Agents; Biological Transport; Blood Platelets; Blood Proteins; Citalopram; Clomipramine; Cytoplasmic Granules; Depression, Chemical; Humans; Imipramine; Kinetics; Propylamines; Protein Binding; Reserpine; Serotonin | 1985 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Medication treatments for panic disorder and social phobia.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders | 1998 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Management of treatment resistant obsessive-compulsive disorder. Algorithms for pharmacotherapy.
Topics: Algorithms; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopamine Antagonists; Drug Resistance; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2002 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Citalopram; Clomipramine; Deep Brain Stimulation; Electric Stimulation Therapy; Electroshock; Humans; Magnetics; Obsessive-Compulsive Disorder; Radiosurgery; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vagus Nerve | 2004 |
Intravenous anti-obsessive agents: a review.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Clomipramine; Drug Administration Schedule; Humans; Infusions, Intravenous; Obsessive-Compulsive Disorder; Pulse Therapy, Drug; Time Factors | 2010 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
16 trial(s) available for citalopram and clomipramine
Article | Year |
---|---|
Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group.
Topics: Adolescent; Adult; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Female; Humans; Male; Propylamines; Psychiatric Status Rating Scales; Random Allocation | 1986 |
Experiments on clinical observation and judgement in the assessment of depression: profiled videotapes and Judgement Analysis.
Topics: Adult; Citalopram; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Propylamines; Psychiatry; Psychological Tests; Videotape Recording | 1986 |
Orthostatic side effects of clomipramine and citalopram during treatment for depression.
Topics: Adult; Citalopram; Clomipramine; Depressive Disorder; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Propylamines; Serotonin Antagonists | 1985 |
Mortality in major affective disorder: relationship to subtype of depression. The Danish University Antidepressant Group.
Topics: Adult; Aged; Citalopram; Clomipramine; Denmark; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Suicide | 1993 |
Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs. patients treated by their family doctors. Danish University Antidepressant Group.
Topics: Citalopram; Clomipramine; Depressive Disorder; Family Practice; Female; Humans; Imipramine; Male; Observer Variation; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 1996 |
The effect of citalopram in panic disorder.
Topics: Adolescent; Adult; Aged; Citalopram; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1997 |
Fenfluramine challenge test in obsessive-compulsive disorder--first results.
Topics: Adult; Citalopram; Clomipramine; Double-Blind Method; Female; Fenfluramine; Humans; Male; Obsessive-Compulsive Disorder; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents | 1997 |
Pharmacokinetic consequences of a citalopram treatment discontinuation.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Substance Withdrawal Syndrome | 1999 |
Citalopram for treatment-resistant obsessive-compulsive disorder.
Topics: Adolescent; Adult; Citalopram; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 1999 |
Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.
Topics: Adolescent; Adult; Aged; Citalopram; Clomipramine; Dose-Response Relationship, Drug; Female; Humans; Long-Term Care; Male; Middle Aged; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2000 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans.
Topics: Adult; Aged; Brain; Cerebral Arteries; Cerebrovascular Circulation; Citalopram; Clomipramine; Double-Blind Method; Female; Gyrus Cinguli; Humans; Hypothalamus; Injections, Intravenous; Male; Middle Aged; Oxygen Radioisotopes; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin; Thalamus | 2005 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study.
Topics: Administration, Oral; Antidepressive Agents; Citalopram; Clomipramine; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Selective Serotonin Reuptake Inhibitors | 2008 |
Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients.
Topics: Adult; Citalopram; Clomipramine; Demography; Drug Resistance; Drug Synergism; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Young Adult | 2008 |
Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5).
Topics: Antidepressive Agents; Citalopram; Clomipramine; Denmark; Depressive Disorder; Double-Blind Method; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Placebos; Secondary Prevention; Severity of Illness Index; Treatment Outcome | 2013 |
82 other study(ies) available for citalopram and clomipramine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Animals; Citalopram; Clomipramine; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Mice; Molecular Structure; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tropanes; Yohimbine | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil.
Topics: Amino Acids; Animals; Citalopram; Clomipramine; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Neurons | 1992 |
Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers.
Topics: Animals; Citalopram; Clomipramine; Clorgyline; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Rats; Receptors, Serotonin; Serotonin Antagonists | 1991 |
Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography.
Topics: Aged; Benztropine; Binding, Competitive; Biological Transport; Brain Chemistry; Brain Mapping; Caudate Nucleus; Citalopram; Clomipramine; Corpus Striatum; Desipramine; Dopamine; Humans; Locus Coeruleus; Mazindol; Medulla Oblongata; Mianserin; Middle Aged; Norepinephrine; Piperazines; Pons; Substantia Nigra | 1991 |
Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups.
Topics: Animals; Body Temperature; Catecholamines; Citalopram; Clomipramine; Desipramine; Flumazenil; Mazindol; Motor Activity; Naltrexone; Nortriptyline; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stress, Psychological; Ultrasonics; Vocalization, Animal | 1990 |
Dopamine-mediated increases in nigral substance P-like immunoreactivity.
Topics: Animals; Citalopram; Clomipramine; Corpus Striatum; Dopamine; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Nomifensine; Propylamines; Radioimmunoassay; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Substance P; Substantia Nigra | 1985 |
In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat.
Topics: Animals; Butaclamol; Citalopram; Clomipramine; Corpus Striatum; Dopamine; In Vitro Techniques; Methamphetamine; Nalidixic Acid; Naphthyridines; Propylamines; Serotonin | 1985 |
Antinociceptive effects of serotonergic reuptake inhibitors in mice.
Topics: Alanine; Analgesics; Animals; Citalopram; Clomipramine; Desipramine; Formaldehyde; Hot Temperature; Male; Mice; Neurotransmitter Uptake Inhibitors; Serotonin Antagonists; Substance P | 1989 |
Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.
Topics: Aged; Animals; Antidepressive Agents; Binding Sites; Brain; Citalopram; Clomipramine; Humans; In Vitro Techniques; Male; Middle Aged; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1989 |
High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
Topics: Amitriptyline; Animals; Citalopram; Clomipramine; Cyclopropanes; Hypothalamus; Imipramine; Kinetics; Male; Milnacipran; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium | 1986 |
Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
Topics: Animals; Cerebral Cortex; Citalopram; Clomipramine; Clorgyline; Kinetics; Male; Membranes; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Selegiline; Serotonin | 1987 |
Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
Topics: Animals; Brain; Cell Membrane; Citalopram; Clomipramine; Imipramine; Kinetics; Male; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Zimeldine | 1988 |
The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes.
Topics: Animals; Brain; Calcium; Citalopram; Clomipramine; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Potassium; Rats; Rats, Inbred Strains; Serotonin; Synaptosomes | 1988 |
Receptor assay based on 3H-imipramine binding.
Topics: Antidepressive Agents; Binding, Competitive; Blood Platelets; Chromatography, Thin Layer; Citalopram; Clomipramine; Humans; Imipramine; Propylamines; Radioligand Assay | 1987 |
Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Carrier Proteins; Cerebral Cortex; Citalopram; Clomipramine; Corpus Striatum; Dopamine; Male; Methamphetamine; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1985 |
Determination of citalopram, amitriptyline and clomipramine in plasma by reversed-phase high-performance liquid chromatography.
Topics: Amitriptyline; Chromatography, High Pressure Liquid; Citalopram; Clomipramine; Humans; Propylamines; Serotonin Antagonists; Spectrophotometry, Ultraviolet | 1985 |
Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats.
Topics: Adaptation, Physiological; Amitriptyline; Animals; Body Temperature; Citalopram; Clomipramine; Dose-Response Relationship, Drug; Hot Temperature; Male; Piperazines; Piperidines; Propylamines; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists | 1984 |
Effects of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-THbetaC) on audiogenic seizures in DBA/2J mice.
Topics: 5-Hydroxytryptophan; Acoustic Stimulation; Animals; Benzofurans; Carbolines; Citalopram; Clomipramine; Clorgyline; Fluoxetine; Harmine; Indoles; Methoxydimethyltryptamines; Mice; Mice, Inbred DBA; N,N-Dimethyltryptamine; Pargyline; Propylamines; Quipazine; Seizures; Selegiline | 1980 |
Antidepressants and serotonin neurons of the raphe.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzofurans; Brain Stem; Citalopram; Clomipramine; Ethers; Fluvoxamine; Imipramine; Indoles; Locus Coeruleus; Male; Microscopy, Fluorescence; Norepinephrine; Oximes; Piperidines; Propylamines; Raphe Nuclei; Rats; Receptors, Serotonin; Serotonin | 1981 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression.
Topics: Animals; Antidepressive Agents; Citalopram; Clomipramine; Disease Models, Animal; Male; Membrane Potentials; Neurons; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 1995 |
Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses.
Topics: Adult; Benzamides; Citalopram; Clomipramine; Drug Interactions; Drug Overdose; Fatal Outcome; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Serotonin | 1993 |
[Studies on lithium potentiation of antidepressant treatment].
Topics: Animals; Biogenic Monoamines; Brain; Citalopram; Clomipramine; Drug Synergism; Lithium; Male; Rats; Rats, Wistar; Receptors, Serotonin | 1994 |
The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes.
Topics: Antidepressive Agents, Tricyclic; Apoptosis; Cells, Cultured; Citalopram; Clomipramine; DNA; Humans; T-Lymphocytes | 1996 |
Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression.
Topics: Animals; Citalopram; Clomipramine; Depression; Dose-Response Relationship, Drug; Electrophysiology; Male; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sleep Deprivation; Zimeldine | 1996 |
Antidepressant induced mania in obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Citalopram; Clomipramine; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder | 1996 |
Dysregulation of bcl-2, c-myc, and Fas expression during tricyclic antidepressant-induced apoptosis in human peripheral lymphocytes.
Topics: Antidepressive Agents, Tricyclic; Apoptosis; Cell Membrane; Citalopram; Clomipramine; fas Receptor; Gene Expression Regulation; Humans; Imipramine; Lymphocytes; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc | 1996 |
Chronic treatment with antidepressants, verapamil, or lithium inhibits the serotonin-induced intracellular calcium response in individual C6 rat glioma cells.
Topics: Animals; Antidepressive Agents; Calcium; Calcium Channel Blockers; Citalopram; Clomipramine; Drug Interactions; Glioma; Intracellular Fluid; Lithium Chloride; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured; Verapamil | 1997 |
Pica and the obsessive-compulsive spectrum disorders.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Citalopram; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pica; Sertraline; Tomography, Emission-Computed, Single-Photon | 1996 |
Tricyclic antidepressant-induced lipidosis in human peripheral monocytes in vitro, as well as in a monocyte-derived cell line, as monitored by spectrofluorimetry and flow cytometry after staining with Nile red.
Topics: Antidepressive Agents, Tricyclic; Cell Line; Citalopram; Clomipramine; Flow Cytometry; Fluorescent Dyes; Humans; Imipramine; Lipidoses; Lipopolysaccharide Receptors; Microscopy, Electron; Microscopy, Fluorescence; Monocytes; Oxazines; Spectrometry, Fluorescence | 1997 |
Density of guanine nucleotide-binding proteins in platelets of patients with major depression: increased abundance of the G alpha i2 subunit and down-regulation by antidepressant drug treatment.
Topics: Adult; Antidepressive Agents; Blood Platelets; Citalopram; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Down-Regulation; Female; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Proteins; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Receptors, Adrenergic, alpha-2; Signal Transduction | 1997 |
Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.
Topics: Allosteric Site; Animals; Antidepressive Agents, Tricyclic; Biological Transport; Carrier Proteins; Cell Line; Citalopram; Clomipramine; Desipramine; Humans; Imipramine; Kidney; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sodium | 1998 |
Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Buspirone; Citalopram; Clomipramine; Delusions; Drug Resistance; Female; Flupenthixol; Humans; Obsessive-Compulsive Disorder; Recurrence; Treatment Outcome | 1998 |
The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation.
Topics: Antidepressive Agents; Apoptosis; Caspase 3; Caspases; Citalopram; Clomipramine; DNA Fragmentation; Flow Cytometry; HL-60 Cells; Humans; Imipramine; In Situ Nick-End Labeling; Leukemia, Promyelocytic, Acute; Reactive Oxygen Species | 1999 |
Citalopram: new indication. No advantage.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1999 |
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Cytochrome P-450 CYP2D6; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Humans; Obsessive-Compulsive Disorder; Phenotype | 1999 |
Alprazolam, citalopram, and clomipramine for stuttering.
Topics: Alprazolam; Anti-Anxiety Agents; Citalopram; Clomipramine; Drug Therapy, Combination; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Stuttering | 2000 |
Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle comparison with clomipramine.
Topics: Action Potentials; Animals; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Guinea Pigs; Papillary Muscles; Selective Serotonin Reuptake Inhibitors | 2000 |
Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-X(L).
Topics: Antidepressive Agents; Apoptosis; bcl-X Protein; Cell Survival; Citalopram; Clomipramine; HL-60 Cells; Humans; Imipramine; Membrane Potentials; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Transfection | 1999 |
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Topics: Animals; Brain Chemistry; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Electrophysiology; Humans; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Rats; Rats, Wistar; Reboxetine; Receptors, Adrenergic, alpha; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2001 |
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Discrimination, Psychological; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Postural Balance; Rats; Rats, Wistar; Reaction Time; Reboxetine; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2001 |
Clinical predictors of drug response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Citalopram; Clomipramine; Drug Resistance; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychological Tests; Random Allocation; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Tricyclic antidepressants prevent the differentiation of monocytes into macrophage-like cells in vitro.
Topics: Antidepressive Agents, Tricyclic; Antigens, Surface; Cell Differentiation; Citalopram; Clomipramine; Humans; Imipramine; Macrophages; Monocytes; Phagocytosis | 2002 |
Differential neurochemical properties of central serotonergic transmission in Roman high- and low-avoidance rats.
Topics: Animals; Anxiety; Autoradiography; Avoidance Learning; Behavior, Animal; Binding, Competitive; Brain; Central Nervous System; Citalopram; Clomipramine; Depression; Fluoxetine; Male; Microdialysis; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Synaptic Transmission; Tritium | 2003 |
Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
Topics: Animals; Animals, Newborn; Behavior, Animal; Citalopram; Clomipramine; Female; Fluoxetine; Maternal-Fetal Exchange; Morphine Dependence; Naloxone; Narcotic Antagonists; Pregnancy; Pregnancy Complications; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2005 |
Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antigens, Nuclear; Behavior, Animal; Body Weight; Brain; Citalopram; Clomipramine; Data Interpretation, Statistical; Female; Immunohistochemistry; Motor Activity; Nerve Tissue Proteins; Pregnancy; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior, Animal; Tryptophan Hydroxylase | 2006 |
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amino Acid Sequence; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Blotting, Western; Cadmium; Cell Line; Cell Membrane; Citalopram; Clomipramine; Cocaine; Cysteine; Dopamine Uptake Inhibitors; Fluoxetine; HeLa Cells; Humans; Immunoprecipitation; Isoleucine; Kinetics; LLC-PK1 Cells; Mazindol; Methionine; Mice; Models, Chemical; Molecular Sequence Data; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Nomifensine; Protein Binding; Protein Structure, Tertiary; Protein Transport; Radiopharmaceuticals; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Stereoisomerism; Substrate Specificity; Tyrosine | 2006 |
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Motor Activity; Paroxetine; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Swimming | 2008 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Effects of anti-depressants on olfactory sensitivity in mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Choice Behavior; Citalopram; Clomipramine; Discrimination, Psychological; Female; Maze Learning; Mice; Odorants; Olfactory Pathways; Time Factors | 2008 |
Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
Topics: Adult; Binding, Competitive; Citalopram; Clomipramine; Down-Regulation; Female; Humans; Hypothalamus; Iodine Radioisotopes; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Thalamus; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2008 |
[Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression].
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carbazoles; Citalopram; Clomipramine; Data Interpretation, Statistical; Depressive Disorder; Female; Humans; International Classification of Diseases; Male; Middle Aged; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors | 2008 |
The identification of inhibitors of Schistosoma mansoni miracidial transformation by incorporating a medium-throughput small-molecule screen.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Anthelmintics; Benzophenanthridines; Calcimycin; Calcium Channel Blockers; Citalopram; Clomipramine; Colforsin; Cyclic AMP; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Immunohistochemistry; Mice; Schistosoma mansoni; Tetradecanoylphorbol Acetate; Triflupromazine | 2010 |
Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients.
Topics: Adolescent; Adult; Aged; Alleles; Amitriptyline; Aryl Hydrocarbon Hydroxylases; Biomarkers, Pharmacological; Citalopram; Clomipramine; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Female; Genetic Association Studies; Humans; Male; Middle Aged; Netherlands; Polymorphism, Genetic | 2011 |
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes.
Topics: Adrenergic beta-3 Receptor Agonists; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; bcl-2-Associated X Protein; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Clomipramine; Cyclic AMP Response Element-Binding Protein; Depression; Hippocampus; Male; Proto-Oncogene Proteins c-bcl-2; Rats; Stress, Psychological; Swimming; Tetrahydronaphthalenes | 2010 |
Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder, Major; Evoked Potentials, Motor; Humans; Injections, Intravenous; Motor Cortex; Placebos; Selective Serotonin Reuptake Inhibitors; Transcranial Magnetic Stimulation | 2010 |
Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Biogenic Monoamines; Citalopram; Clomipramine; Depression; Disease Models, Animal; Drug Administration Schedule; Feeding Behavior; Hippocampus; Learning; Long-Term Potentiation; Male; Maze Learning; Memory; Motor Activity; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Swimming; Time Factors | 2011 |
Distance from source of reward as a marker for extinction-induced "despair": modulation by the antidepressants clomipramine and citalopram.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Clomipramine; Conditioning, Operant; Depressive Disorder, Major; Disease Models, Animal; Exploratory Behavior; Extinction, Psychological; Male; Rats; Rats, Wistar; Reaction Time; Reward; Time Factors | 2012 |
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Cyclohexanols; Desipramine; Drug Interactions; Fluvoxamine; Male; Methadone; Mice; Mice, Inbred ICR; Morpholines; Nociception; Pain Threshold; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Interaction of injectable neurotropic drugs with the red cell membrane.
Topics: Central Nervous System Agents; Chlorpromazine; Citalopram; Clomipramine; Clonazepam; Diazepam; Erythrocytes; Humans; Injections; Levetiracetam; Microscopy, Electron, Scanning; Neurotransmitter Agents; Phenobarbital; Phenytoin; Piracetam; Valproic Acid | 2014 |
Antidepressants and the risk of hyponatremia: a Danish register-based population study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Denmark; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Incidence; Male; Mianserin; Middle Aged; Mirtazapine; Registries; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride | 2016 |
Obsession of pregnancy: Does it exist?
Topics: Attitude to Health; Citalopram; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Female; Fluoxetine; GABA Modulators; Humans; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2017 |
Distribution of clomipramine, citalopram, midazolam, and metabolites in skeletal tissue after chronic dosing in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Bone and Bones; Chromatography, High Pressure Liquid; Citalopram; Clomipramine; Limit of Detection; Male; Midazolam; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2019 |
Acute Inhibitory Effects of Antidepressants on Lacrimal Gland Secretion in the Anesthetized Rat.
Topics: Animals; Antidepressive Agents; Cholinergic Antagonists; Citalopram; Clomipramine; Dry Eye Syndromes; Evoked Potentials, Visual; Lacrimal Apparatus; Methacholine Chloride; Miotics; Rats; Tears | 2021 |
FKBP5 blockade may provide a new horizon for the treatment of stress-associated disorders: An in-silico study.
Topics: Citalopram; Clomipramine; Duloxetine Hydrochloride; Fluoxetine; Humans; Sertraline; United States | 2023 |